The genetics of induced pluripotency

Reproduction

Volumn 139, Issue 1, 2010, Pages 35-44

  Ralston, Amy ^a   Rossant, Janet ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RELATED RECEPTOR BETA; KRUPPEL LIKE FACTOR 4; MICRORNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

CELL FUNCTION; DEVELOPMENTAL GENE; DEVELOPMENTAL GENETICS; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GENE FUNCTION; HUMAN; NONHUMAN; PLURIPOTENCY; PLURIPOTENT STEM CELL; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; REVIEW;

ANIMALS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICRORNAS; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ESTROGEN; SOXB1 TRANSCRIPTION FACTORS;

EID: 75149166125     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-09-0024     Document Type: Review

References (98)

1. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N & Lovell-Badge R 2003 Multipotent cell lineages in early mouse development depend on SOX2 function. Genes and Development 17 126-140.
2. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K et al. 2006 A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 315-326.
3. Blelloch R, Venere M, Yen J & Ramalho-Santos M 2007 Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 1 245-247.
4. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG et al. 2005 Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122 947-956.
5. Brons IG, Smithers LE, Trotter MW, Rugg-Gunn P, Sun B, Chuva de Sousa Lopes SM, Howlett SK, Clarkson A, Ahrlund-Richter L, Pedersen RA et al. 2007 Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448 191-195.
6. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K & Dalton S 2005 LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132 885-896.
7. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S & Smith A 2003 Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113 643-655.
8. Chambers I, Silva J, Colby D, Nichols J, Nijmeijer B, Robertson M, Vrana J, Jones K, Grotewold L & Smith A 2007 Nanog safeguards pluripotency and mediates germline development. Nature 450 1230-1234.
9. Chazaud C, Yamanaka Y, Pawson T & Rossant J 2006 Early lineage segregation between epiblast and primitive endoderm in mouse blastocysts through the Grb2-MAPK pathway. Developmental Cell 10 615-624.
10. Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, Wong E, Orlov YL, Zhang W, Jiang J et al. 2008 Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133 1106-1117.
11. Davis AC, Wims M, Spotts GD, Hann SR & Bradley A 1993 A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes and Development 7 671-682.
12. Dubois NC, Adolphe C, Ehninger A, Wang RA, Robertson EJ & Trumpp A 2008 Placental rescue reveals a sole requirement for c-Myc in embryonic erythroblast survival and hematopoietic stem cell function. Development 135 2455-2465.
13. Ema M, Mori D, Niwa H, Hasegawa Y, Yamanaka Y, Hitoshi S, Mimura J, Kawabe Y, Hosoya T, Morita M et al. 2008 Kruppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs. Cell Stem Cell 3 555-567.
14. Evans MJ & Kaufman MH 1981 Establishment in culture of pluripotential cells from mouse embryos. Nature 292 154-156.
15. Feng B, Jiang J, Kraus P, Ng JH, Heng JC, Chan YS, Yaw LP, Zhang W, Loh YH, Han J et al. 2009a Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nature Cell Biology 11 197-203.
16. Feng B, Ng JH, Heng JC & Ng HH 2009b Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 4 301-312.
17. Guan K, Nayernia K, Maier LS, Wagner S, Dressel R, Lee JH, Nolte J, Wolf F, Li M, Engel W et al. 2006 Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 440 1199-1203.
18. Guo Y, Chen Y, Ito H, Watanabe A, Ge X, Kodama T & Aburatani H 2006 Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene 384 51-61.
19. Guo G, Yang J, Nichols J, Hall JS, Eyres I, Mansfield W & Smith A 2009 Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 136 1063-1069.
20. Hatano SY, Tada M, Kimura H, Yamaguchi S, Kono T, Nakano T, Suemori H, Nakatsuji N & Tada T 2005 Pluripotential competence of cells associated with Nanog activity. Mechanisms of Development 122 67-79.
21. Hochedlinger K, Yamada Y, Beard C & Jaenisch R 2005 Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121 465-477.
22. Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, Muhlestein W & Melton DA 2008 Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nature Biotechnology 26 1269-1275.
23. Ivanova N, Dobrin R, Lu R, Kotenko I, Levorse J, DeCoste C, Schafer X, Lun Y & Lemischka IR 2006 Dissecting self-renewal in stem cells with RNA interference. Nature 442 533-538.
24. Jiang J, Chan YS, Loh YH, Cai J, Tong GQ, Lim CA, Robson P, Zhong S & Ng HH 2008 A core Klf circuitry regulates self-renewal of embryonic stem cells. Nature Cell Biology 10 353-360.
25. Judson RL, Babiarz JE, Venere M & Blelloch R 2009 Embryonic stem cell-specific microRNAs promote induced pluripotency. Nature Biotechnology 27 459-461.
26. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P & Woltjen K 2009 Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458 771-775.
27. Kanatsu-Shinohara M, Inoue K, Lee J, Yoshimoto M, Ogonuki N, Miki H, Baba S, Kato T, Kazuki Y, Toyokuni S et al. 2004 Generation of pluripotent stem cells from neonatal mouse testis. Cell 119 1001-1012.
28. Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, Yang VW & Kaestner KH 2002 The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129 2619-2628.
29. Kehler J, Tolkunova E, Koschorz B, Pesce M, Gentile L, Boiani M, Lomeli H, Nagy A, McLaughlin KJ, Scholer HR et al. 2004 Oct4 is required for primordial germ cell survival. EMBO Reports 5 1078-1083.
30. Kidder BL, Yang J & Palmer S 2008 Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells. PLoS ONE 3 e3932.
31. Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Arauzo-Bravo MJ, Ruau D, Han DW, Zenke M et al. 2008 Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454 646-650.
32. Kim JB, Sebastiano V, Wu G, Arauzo-Bravo MJ, Sasse P, Gentile L, Ko K, Ruau D, Ehrich M, van den Boom D et al. 2009 Oct4-induced pluripotency in adult neural stem cells. Cell 136 411-419.
33. Knoepfler PS 2008 Why myc? An unexpected ingredient in the stem cell cocktail Cell Stem Cell 2 18-21.
34. Knoepfler PS, Cheng PF & Eisenman RN 2002 N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes and Development 16 2699-2712.
35. Knoepfler PS, Zhang XY, Cheng PF, Gafken PR, McMahon SB & Eisenman RN 2006 Myc influences global chromatin structure. EMBO Journal 25 2723-2734.
36. Kopp JL, Ormsbee BD, Desler M & Rizzino A 2008 Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 26 903-911.
37. Koscianska E, Baev V, Skreka K, Oikonomaki K, Rusinov V, Tabler M & Kalantidis K 2007 Prediction and preliminary validation of oncogene regulation by miRNAs. BMC Molecular Biology 8 79.
38. Kumar MS, Lu J, Mercer KL, Golub TR & Jacks T 2007 Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nature Genetics 39 673-677.
39. Kuo CT, Veselits ML, Barton KP, Lu MM, Clendenin C & Leiden JM 1997 The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes and Development 11 2996-3006.
40. Kuroda T, Tada M, Kubota H, Kimura H, Hatano SY, Suemori H, Nakatsuji N & Tada T 2005 Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Molecular and Cellular Biology 25 2475-2485.
41. Lengner CJ, Camargo FD, Hochedlinger K, Welstead GG, Zaidi S, Gokhale S, Scholer HR, Tomilin A & Jaenisch R 2007 Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 1 403-415.
42. Li Y, McClintick J, Zhong L, Edenberg HJ, Yoder MC & Chan RJ 2005 Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 105 635-637.
43. Li J, Pan G, Cui K, Liu Y, Xu S & Pei D 2007 A dominant-negative form of mouse SOX2 induces trophectoderm differentiation and progressive polyploidy in mouse embryonic stem cells. Journal of Biological Chemistry 282 19481-19492.
44. Li W, Wei W, Zhu S, Zhu J, Shi Y, Lin T, Hao E, Hayek A, Deng H & Ding S 2009 Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4 16-19.
45. Liu H, Zhu F, Yong J, Zhang P, Hou P, Li H, Jiang W, Cai J, Liu M, Cui K et al. 2008 Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell 3 587-590.
46. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J et al. 2006 The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nature Genetics 38 431-440.
47. Luo J, Sladek R, Bader JA, Matthyssen A, Rossant J & Giguere V 1997 Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-beta. Nature 388 778-782.
48. Maherali N & Hochedlinger K 2008 Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3 595-605.
49. Martin GR 1981 Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. PNAS 78 7634-7638.
50. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, Takahashi K, Okochi H, Okuda A, Matoba R, Sharov AA et al. 2007 Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nature Cell Biology 9 625-635.
51. Matsui Y, Zsebo K & Hogan BL 1992 Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 70 841-847.
52. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M & Yamanaka S 2003 The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113 631-642.
53. Miyagi S, Masui S, Niwa H, Saito T, Shimazaki T, Okano H, Nishimoto M, Muramatsu M, Iwama A & Okuda A 2008 Consequence of the loss of Sox2 in the developing brain of the mouse. FEBS Letters 582 2811-2815.
54. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N & Yamanaka S 2008 Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnology 26 101-106.
55. Nakatake Y, Fukui N, Iwamatsu Y, Masui S, Takahashi K, Yagi R, Yagi K, Miyazaki J, Matoba R, Ko MS et al. 2006 Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells. Molecular and Cellular Biology 26 7772-7782.
56. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H & Smith A 1998 Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95 379-391.
57. Niwa H, Miyazaki J & Smith AG 2000 Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nature Genetics 24 372-376.
58. Niwa H, Ogawa K, Shimosato D & Adachi K 2009 A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 460 118-122.
59. Okita K, Nakagawa M, Hyenjong H, Ichisaka T & Yamanaka S 2008 Generation of mouse induced pluripotent stem cells without viral vectors. Science 322 949-953.
60. Okumura-Nakanishi S, Saito M, Niwa H & Ishikawa F 2005 Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. Journal of Biological Chemistry 280 5307-5317.
61. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW & Daley GQ 2008 Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451 141-146.
62. Polesskaya A, Cuvellier S, Naguibneva I, Duquet A, Moss EG & Harel-Bellan A 2007 Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes and Development 21 1125-1138.
63. Que J, Okubo T, Goldenring JR, Nam KT, Kurotani R, Morrisey EE, Taranova O, Pevny LH & Hogan BL 2007 Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm. Development 134 2521-2531.
64. Richards M, Tan SP, Tan JH, Chan WK & Bongso A 2004 The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22 51-64.
65. Rossant J 2008 Stem cells and early lineage development. Cell 132 527-531.
66. Rowland BD, Bernards R & Peeper DS 2005 The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nature Cell Biology 7 1074-1082.
67. Scholer HR, Dressler GR, Balling R, Rohdewohld H & Gruss P 1990 Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO Journal 9 2185-2195.
68. Segre JA, Bauer C & Fuchs E 1999 Klf4 is a transcription factor required for establishing the barrier function of the skin. Nature Genetics 22 356-360.
69. Sekkai D, Gruel G, Herry M, Moucadel V, Constantinescu SN, Albagli O, Tronik-Le Roux D, Vainchenker W & Bennaceur-Griscelli A 2005 Microarray analysis of LIF/Stat3 transcriptional targets in embryonic stem cells. Stem Cells 23 1634-1642.
70. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR & Ding S 2008 A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2 525-528.
71. Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen TW & Smith A 2008 Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biology 6 e253.
72. Simmons DG & Cross JC 2005 Determinants of trophoblast lineage and cell subtype specification in the mouse placenta. Developmental Biology 284 12-24.
73. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M et al. 2009 Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136 964-977.
74. Stadtfeld M, Brennand K & Hochedlinger K 2008a Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Current Biology 18 890-894.
75. Stadtfeld M, Nagaya M, Utikal J, Weir G & Hochedlinger K 2008b Induced pluripotent stem cells generated without viral integration. Science 322 945-949.
76. Tada M, Takahama Y, Abe K, Nakatsuji N & Tada T 2001 Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Current Biology 11 1553-1558.
77. Takahashi K & Yamanaka S 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 663-676.
78. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K & Yamanaka S 2007 Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 861-872.
79. Taranova OV, Magness ST, Fagan BM, Wu Y, Surzenko N, Hutton SR & Pevny LH 2006 SOX2 is a dose-dependent regulator of retinal neural progenitor competence. Genes and Development 20 1187-1202.
80. Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, Gardner RL & McKay RD 2007 New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448 196-199.
81. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS & Jones JM 1998 Embryonic stem cell lines derived from human blastocysts. Science 282 1145-1147.
82. Tomioka M, Nishimoto M, Miyagi S, Katayanagi T, Fukui N, Niwa H, Muramatsu M & Okuda A 2002 Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Research 30 3202-3213.
83. Viswanathan SR, Daley GQ & Gregory RI 2008 Selective blockade of microRNA processing by Lin28. Science 320 97-100.
84. Walker E, Ohishi M, Davey RE, Zhang W, Cassar PA, Tanaka TS, Der SD, Morris Q, Hughes TR, Zandstra PW et al. 2007 Prediction and testing of novel transcriptional networks regulating embryonic stem cell self-renewal and commitment. Cell Stem Cell 1 71-86.
85. Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW & Orkin SH 2006 A protein interaction network for pluripotency of embryonic stem cells. Nature 444 364-368.
86. Wang Y, Medvid R, Melton C, Jaenisch R & Blelloch R 2007 DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nature Genetics 39 380-385.
87. Wang Y, Baskerville S, Shenoy A, Babiarz JE, Baehner L & Blelloch R 2008 Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nature Genetics 40 1478-1483.
88. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE & Jaenisch R 2007 In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448 318-324.
89. West JA, Viswanthan SR, Yabuuchi A, Cunniff K, Takeuchi A, Park IH, Sero JE, Zhu H, Perez-Atayde A, Frazier AL et al. 2009 A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature 460 909-913.
90. Wilmut I, Schnieke AE, McWhir J, Kind AJ & Campbell KH 1997 Viable offspring derived from fetal and adult mammalian cells. Nature 385 810-813.
91. Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, Pasche AC, Knabenhans C, Macdonald HR & Trumpp A 2004 c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes and Development 18 2747-2763.
92. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hamalainen R, Cowling R, Wang W, Liu P, Gertsenstein M et al. 2009 piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458 766-770.
93. Yamanaka Y, Ralston A, Stephenson RO & Rossant J 2006 Cell and molecular regulation of the mouse blastocyst. Developmental Dynamics 235 2301-2314.
94. Yang DH & Moss EG 2003 Temporally regulated expression of Lin-28 in diverse tissues of the developing mouse. Gene Expression Patterns 3 719-726.
95. Ying QL, Nichols J, Chambers I & Smith A 2003 BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115 281-292.
96. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R et al. 2007 Induced pluripotent stem cell lines derived from human somatic cells. Science 318 1917-1920.
97. Yuan H, Corbi N, Basilico C & Dailey L 1995 Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes and Development 9 2635-2645.
98. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y et al. 2009 Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4 381-384.